Louis Moore Bacon's ELV Position Overview
Louis Moore Bacon (via Moore Capital Management, Lp) currently holds 30.0K shares of Elevance Health, Inc. (ELV) worth $9.69 M, representing 0.13% of the portfolio. First purchased in 2015-Q1, this long-term strategic position has been held for 43 quarters.
Based on 13F filings since 2013, Louis Moore Bacon has maintained a long-term strategic position in ELV, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2015, adding 129.9K shares. Largest reduction occurred in Q3 2015, reducing 108.2K shares.
Analysis based on 13F filings available since 2013 Q2
Louis Moore Bacon's Elevance Health (ELV) Holding Value Over Time
Track share changes against reported price movement
Quarterly Elevance Health (ELV) Trades by Louis Moore Bacon
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2015 | +13,297 | New Buy | 13,297 | $154.40 |
| Q2 2015 | +129,919 | Add 977.05% | 143,216 | $164.14 |
| Q3 2015 | -108,216 | Reduce 75.56% | 35,000 | $140.00 |
| Q4 2015 | -35,000 | Sold Out | 35,000 | $0.00 |
| Q4 2020 | +33,909 | New Buy | 33,909 | $321.09 |
| Q1 2021 | -33,909 | Sold Out | 33,909 | $0.00 |
| Q1 2022 | +24,434 | New Buy | 24,434 | $491.20 |
| Q2 2022 | -24,434 | Sold Out | 24,434 | $0.00 |
| Q1 2023 | +1,000 | New Buy | 1,000 | $459.81 |
| Q2 2023 | -1,000 | Sold Out | 1,000 | $0.00 |
| Q2 2024 | +20,000 | New Buy | 20,000 | $541.86 |
| Q3 2024 | +20,000 | Add 100.00% | 40,000 | $520.00 |
| Q4 2024 | -38,986 | Reduce 97.46% | 1,014 | $368.90 |
| Q1 2025 | +25,528 | Add 2517.55% | 26,542 | $434.96 |
| Q2 2025 | -14,521 | Reduce 54.71% | 12,021 | $388.96 |
| Q3 2025 | +17,953 | Add 149.35% | 29,974 | $323.12 |
Louis Moore Bacon's Elevance Health Investment FAQs
Louis Moore Bacon first purchased Elevance Health, Inc. (ELV) in Q1 2015, acquiring 13,297 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Louis Moore Bacon has held Elevance Health, Inc. (ELV) for 43 quarters since Q1 2015. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Louis Moore Bacon's largest addition to Elevance Health, Inc. (ELV) was in Q2 2015, adding 143,216 shares worth $23.51 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Louis Moore Bacon's firm, Moore Capital Management, Lp, owns 29,974 shares of Elevance Health, Inc. (ELV), valued at approximately $9.69 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Elevance Health, Inc. (ELV) represents approximately 0.13% of Louis Moore Bacon's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Louis Moore Bacon's peak holding in Elevance Health, Inc. (ELV) was 143,216 shares, as reported at the end of Q2 2015. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.